Total Payments
$618.69
2024 Payments
$219.06
Companies
20
Transactions
37
Medicare Patients
3,653
Medicare Billing
$414,163
Payment Breakdown by Category
Food & Beverage$606.77 (98.1%)
Education$11.92 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $606.77 | 36 | 98.1% |
| Education | $11.92 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $79.80 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $70.26 | 4 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $52.57 | 3 | $0 (2024) |
| Eisai Inc. | $47.77 | 2 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $40.14 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $37.46 | 2 | $0 (2022) |
| PFIZER INC. | $37.14 | 3 | $0 (2024) |
| Kyowa Kirin, Inc. | $31.72 | 2 | $0 (2024) |
| MEDIVATION FIELD SOLUTIONS LLC | $29.15 | 2 | $0 (2018) |
| Celgene Corporation | $24.52 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $219.06 | 12 | Janssen Biotech, Inc. ($33.53) |
| 2023 | $129.68 | 7 | JAZZ PHARMACEUTICALS INC. ($40.14) |
| 2022 | $57.71 | 3 | GENZYME CORPORATION ($23.42) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2018 | $97.70 | 7 | MEDIVATION FIELD SOLUTIONS LLC ($29.15) |
| 2017 | $102.62 | 7 | Novartis Pharmaceuticals Corporation ($70.26) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $18.83 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/18/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: DESMOID TUMORS | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Monoclonal Antibody | ||||||
| 08/19/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.52 | General |
| Category: Hematology | ||||||
| 08/07/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: ETONOGESTREL | ||||||
| 07/29/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Oncology | ||||||
| 06/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Oncology | ||||||
| 06/03/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: ONCOLOGY | ||||||
| 05/06/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $24.04 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Respiratory | ||||||
| 02/06/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2023 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/23/2023 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $22.60 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/16/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Oncology | ||||||
| 07/17/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: Oncology | ||||||
| 06/12/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Monoclonal Antibody | ||||||
| 05/15/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 02/28/2023 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/20/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Oncology | ||||||
| 10/31/2022 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Oncology | ||||||
| 06/03/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 11/14/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/09/2018 | MEDIVATION FIELD SOLUTIONS LLC | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 1,163 | 2,729 | $237,792 | $102,829 |
| 2021 | 11 | 1,323 | 3,911 | $344,509 | $164,946 |
| 2020 | 11 | 1,167 | 3,762 | $337,931 | $146,387 |
Total Patients
3,653
Total Services
10,402
Medicare Billing
$414,163
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 358 | 852 | $151,656 | $70,630 | 46.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 81 | $19,197 | $10,104 | 52.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 313 | 847 | $26,257 | $6,508 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $10,170 | $4,707 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 77 | $9,317 | $4,380 | 47.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 48 | $6,192 | $2,627 | 42.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 308 | 765 | $11,475 | $2,273 | 19.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,324 | $1,527 | 45.9% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 17 | 17 | $204.00 | $74.05 | 36.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 393 | 1,289 | $217,746 | $115,011 | 52.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 52 | 87 | $19,695 | $11,263 | 57.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 68 | 68 | $22,122 | $11,239 | 50.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 337 | 1,230 | $38,130 | $9,544 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 118 | $13,706 | $7,366 | 53.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 65 | $8,385 | $3,580 | 42.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 325 | 988 | $14,820 | $2,964 | 20.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $5,240 | $2,166 | 41.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,851 | $1,309 | 45.9% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2021 | 14 | 29 | $1,682 | $456.24 | 27.1% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 11 | 11 | $132.00 | $48.18 | 36.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 372 | 1,420 | $228,620 | $106,876 | 46.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 293 | 1,048 | $32,488 | $8,080 | 24.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 53 | 53 | $16,324 | $7,450 | 45.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 116 | $12,760 | $6,231 | 48.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 28 | 103 | $13,287 | $5,772 | 43.4% |
About Dr. David Croy, MD
Dr. David Croy, MD is a Hematology & Oncology healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164499588.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Croy, MD has received a total of $618.69 in payments from pharmaceutical and medical device companies, with $219.06 received in 2024. These payments were reported across 37 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($606.77).
As a Medicare-enrolled provider, Croy has provided services to 3,653 Medicare beneficiaries, totaling 10,402 services with total Medicare billing of $414,163. Data is available for 3 years (2020–2022), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Joplin, MO
- Active Since 03/03/2006
- Last Updated 03/16/2016
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1164499588
Products in Payments
- Lenvima (Drug) $47.77
- ERLEADA (Drug) $46.13
- ZEPZELCA (Drug) $40.14
- KEYTRUDA (Biological) $37.46
- Poteligeo (Drug) $31.72
- XTANDI (Drug) $29.15
- JADENU (Drug) $27.95
- REBLOZYL (Biological) $24.52
- clonoSEQ (Device) $24.04
- JEVTANA (Drug) $23.42
- AYVAKIT (Drug) $22.60
- DARZALEX (Biological) $21.62
- TASIGNA (Drug) $21.31
- AIRSUPRA (Drug) $21.19
- RYDAPT (Drug) $21.00
- ADSTILADRIN (Biological) $19.77
- OGSIVEO (Drug) $19.26
- PEMAZYRE (Drug) $18.83
- TAGRISSO (Drug) $17.79
- Rezlidhia (Drug) $14.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Joplin
Dr. Anisa Hassan, M.d, M.D
Hematology & Oncology — Payments: $14,208
Hematology & Oncology $14,208
Matthew Miller, D.o, D.O
Hematology & Oncology — Payments: $7,036
Hematology & Oncology $7,036
Regine Leconte, M.d, M.D
Hematology & Oncology — Payments: $6,937
Hematology & Oncology $6,937
Dr. Kerry Williams-Wuch, M.d, M.D
Hematology & Oncology — Payments: $3,800
Hematology & Oncology $3,800
Samir Dalia, Md, MD
Hematology & Oncology — Payments: $3,276
Hematology & Oncology $3,276
Amir Anis
Hematology & Oncology — Payments: $3,158
Hematology & Oncology $3,158